The impact of PPARγ genetic variants on IBD susceptibility and IBD disease course

PPAR Research

Volumn , Issue , 2012, Pages

  Mwinyi, Jessica ^a   Grete Wenger, Christa ^a   Eloranta, Jyrki J ^a   Kullak Ublick, Gerd A ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADULT; ARTICLE; BIOINFORMATICS; DISEASE ACTIVITY; DISEASE COURSE; ENTERITIS; EXON; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84858330062     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2012/349469     Document Type: Article

References (37)

1. Bosani M., Ardizzone S., Porro G. B., Biologic targeting in the treatment of inflammatory bowel diseases Biologics 2009 3 77 97
2. Weersma R. K., Stokkers P. C., van Bodegraven A. A., van Hogezand R. A., Verspaget H. W., De Jong D. J., Van Der Woude C. J., Oldenburg B., Linskens R. K., Festen E. A. M., Van Der Steege G., Hommes D. W., Crusius J. B. A., Wijmenga C., Nolte M., Dijkstra G., Molecular prediction of disease risk and severity in a large Dutch Crohn's disease cohort Gut 2009 58 3 388 395
3. Ferguson L. R., Huebner C., Petermann I., Gearry R. B., Barclay M. L., Demmers P., McCulloch A., Han D. H., Single nucleotide polymorphism in the tumor necrosis factor-alpha gene affects inflammatory bowel diseases risk World Journal of Gastroenterology 2008 14 29 4652 4661
4. Glas J., Stallhofer J., Ripke S., Wetzke M., Pfennig S., Klein W., Epplen J. T., Griga T., Schiemann U., Lacher M., Koletzko S., Folwaczny M., Lohse P., Gke B., Ochsenkhn T., Mller-Myhsok B., Brand S., Novel genetic risk markers for ulcerative colitis in the IL2/IL21 region are in epistasis with IL23R and suggest a common genetic background for ulcerative colitis and celiac disease American Journal of Gastroenterology 2009 104 7 1737 1744
5. Hugot J. P., Chamaillard M., Zouali H., Lesage S., Cézard J. P., Belaiche J., Almer S., Tysk C., O'morain C. A., Gassull M., Binder V., Finkel Y., Cortot A., Modigliani R., Laurent-Puig P., Gower-Rousseau C., Macry J., Colombel J. F., Sahbatou M., Thomas G., Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease Nature 2001 411 6837 599 603 (Pubitemid 32531408)
6. Ogura Y., Bonen D. K., Inohara N., Nicolae D. L., Chen F. F., Ramos R., Britton H., Moran T., Karaliuskas R., Duerr R. H., Achkar J. P., Brant S. R., Bayless T. M., Kirschner B. S., Hanauer S. B., Nez G., Cho J. H., A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease Nature 2001 411 6837 603 606 (Pubitemid 32531409)
7. McGovern D., Ahmad T., New IBD genes? Gut 2005 54 8 1060 1061 (Pubitemid 41025893)
8. Rigoli L., Romano C., Caruso R. A., Presti M. A. L., Di Bella C., Procopio V., Giudice G. L., Amorini M., Costantino G., Sergi M. D., Cuppari C., Calabr G. E., Gallizzi R., Salpietro C. D., Fries W., Clinical significance of NOD2/CARD15 and Toll-like receptor 4 gene single nucleotide polymorphisms in inflammatory bowel disease World Journal of Gastroenterology 2008 14 28 4454 4461
9. Dubuquoy L., Rousseaux C., Thuru X., Peyrin-Biroulet L., Romano O., Chavatte P., Chamaillard M., Desreumaux P., PPAR as a new therapeutic target in inflammatory bowel diseases Gut 2006 55 9 1341 1349 (Pubitemid 44277368)
10. Kliewer S. A., Umesono K., Noonan D. J., Heyman R. A., Evans R. M., Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors Nature 1992 358 6389 771 774
11. Fajas L., Auboeuf D., Raspé E., Schoonjans K., Lefebvre A. M., Saladin R., Najib J., Laville M., Fruchart J. C., Deeb S., Vidal-Puig A., Flier J., Briggs M. R., Staels B., Vidal H., Auwerx J., The organization, promoter analysis, and expression of the human PPAR gene Journal of Biological Chemistry 1997 272 30 18779 18789 (Pubitemid 27318225)
12. Desreumaux P., Dubuquoy L., Nutten S., Peuchmaur M., Englaro W., Schoonjans K., Derijard B., Desvergne B., Wahli W., Chambon P., Leibowitz M. D., Colombel J. F., Auwerx J., Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor (PPAR ) heterodimer: a basis for new therapeutic strategies Journal of Experimental Medicine 2001 193 7 827 838 (Pubitemid 32524532)
13. Yang X. Y., Wang L. H., Chen T., Hodge D. R., Resau J. H., DaSilva L., Farrar W. L., Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor (PPAR ) agonists. PPAR co-association with transcription factor NFAT Journal of Biological Chemistry 2000 275 7 4541 4544 (Pubitemid 30108833)
14. Bassaganya-Riera J., Reynolds K., Martino-Catt S., Cui Y., Hennighausen L., Gonzalez F., Rohrer J., Benninghoff A. U., Hontecillas R., Activation of PPAR and by conjugated linoleic acid mediates protection from experimental inflammatory bowel disease Gastroenterology 2004 127 3 777 791 (Pubitemid 39208411)
15. Desreumaux P., Dubuquoy L., PPAR agonists as a new class of effective treatment for ulcerative colitis Inflammatory Bowel Diseases 2009 15 6 959 960
16. Yen C. J., Beamer B. A., Negri C., Silver K., Brown K. A., Yarnall D. P., Burns D. K., Roth J., Shuldiner A. R., Molecular scanning of the human peroxisome proliferator activated receptor (hPPAR ) gene in diabetic Caucasians: identification of a Pro12Ala PPAR 2 missense mutation Biochemical and Biophysical Research Communications 1997 241 2 270 274 (Pubitemid 28020091)
17. Deeb S. S., Fajas L., Nemoto M., Pihlajamaki J., Mykkanen L., Kuusisto J., Laakso M., Fujimoto W., Auwerx J., A Pro12Ala substitution in PPAR 2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity Nature Genetics 1998 20 3 284 287 (Pubitemid 28507675)
18. Pittet V., Juillerat P., Mottet C., Felley C., Ballabeni P., Burnand B., Michetti P., Vader J. P., Cohort profile: the Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS) International Journal of Epidemiology 2009 38 4 922 931
19. Heude B., Pelloux V., Forhan A., Bedel J. -F., Lacorte J. -M., Clément K., Charles M. -A., De Agostini M., Ducimetire P., Kaminski M., Saurel-Cubizolles M. J., Dargent P., Fritel X., Larroque B., Lelong N., Marchand L., Nabet C., Annesi-Maesano I., Slama R., Goua V., Magnin G., Hankard R., Thiebaugeorges O., Schweitzer M., Foliguet B., Job-Spira N., Association of the Pro12Ala and C1431T variants of PPAR and their haplotypes with susceptibility to gestational diabetes Journal of Clinical Endocrinology and Metabolism 2011 96 10 E1656 E1660
20. Meirhaeghe A., Fajas L., Helbecque N., Cottel D., Auwerx J., Deeb S. S., Amouyel P., Impact of the Peroxisome Proliferator Activated Receptor 2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus International Journal of Obesity 2000 24 2 195 199 (Pubitemid 30107568)
21. Valve R., Sivenius K., Miettinen R., Pihlajamki J., Rissanen A., Deeb S. S., Auwerx J., Uusitupa M., Laakso M., Two polymorphisms in the peroxisome proliferator-activated receptor- gene are associated with severe overweight among obese women Journal of Clinical Endocrinology and Metabolism 1999 84 10 3708 3712 (Pubitemid 30645229)
22. Rousseaux C., Lefebvre B., Dubuquoy L., Lefebvre P., Romano O., Auwerx J., Metzger D., Wahli W., Desvergne B., Naccari G. C., Chavatte P., Farce A., Bulois P., Cortot A., Colombel J. F., Desreumaux P., Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator- activated receptor- Journal of Experimental Medicine 2005 201 8 1205 1215 (Pubitemid 40629065)
23. Altshuler D., Hirschhorn J. N., Klannemark M., Lindgren C. M., Vohl M. C., Nemesh J., Lane C. R., Schaffner S. F., Bolk S., Brewer C., Tuomi T., Gaudet D., Hudson T. J., Daly M., Groop L., Lander E. S., The common PPAR Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes Nature Genetics 2000 26 1 76 80
24. Landi S., Moreno V., Gioia-Patricola L., Guino E., Navarro M., De Oca J., Capella G., Canzian F., Association of common polymorphisms in inflammatory genes interleukin (IL)6, IL8, tumor necrosis factor, NFKB1, and peroxisome proliferator-activated receptor with colorectal cancer Cancer Research 2003 63 13 3560 3566 (Pubitemid 36793036)
25. Koh W. P., Yuan J. M., van den Berg D., Ingles S. A., Yu M. C., Peroxisome proliferator-activated receptor (PPAR) gene polymorphisms and colorectal cancer risk among Chinese in Singapore Carcinogenesis 2006 27 9 1797 1802 (Pubitemid 44288662)
26. Meirhaeghe A., Fajas L., Helbecque N., Cottel D., Lebel P., Dallongeville J., Deeb S., Auwerx J., Amouyel P., A genetic polymorphism of the peroxisome proliferator-activated receptor gene influences plasma leptin levels in obese humans Human Molecular Genetics 1998 7 3 435 440 (Pubitemid 28120633)
27. Jiang J., Gajalakshmi V., Wang J., Kuriki K., Suzuki S., Nakamura S., Akasaka S., Ishikawa H., Tokudome S., Influence of the C161T but not Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma on colorectal cancer in an Indian population Cancer Science 2005 96 8 507 512 (Pubitemid 41387303)
28. Wang X. L., Oosterhof J., Duarte N., Peroxisome proliferator-activated receptor C161 → T polymorphism and coronary artery disease Cardiovascular Research 1999 44 3 588 594 (Pubitemid 30012062)
29. Chao T. H., Li Y. H., Chen J. H., Wu H. L., Shi G. Y., Liu P. Y., Tsai W. C., Guo H. R., The 161TT genotype in the exon 6 of the peroxisome-proliferator- activated receptor gene is associated with premature acute myocardial infarction and increased lipid peroxidation in habitual heavy smokers Clinical Science 2004 107 5 461 466
30. Zafarmand M. H., van der Schouw Y. T., Grobbee D. E., de Leeuw P. W., Bots M. L., Peroxisome proliferator-activated receptor gamma-2 P12A polymorphism and risk of acute myocardial infarction, coronary heart disease and ischemic stroke: a case-cohort study and meta-analyses Vascular Health and Risk Management 2008 4 2 427 436 (Pubitemid 351711971)
31. Xu W., Li Y., Wang X., PPARgamma polymorphisms and cancer risk: a meta-analysis involving 3238 subjects Oncology Reports 2010 24 2 579 585
32. Gouda H. N., Sagoo G. S., Harding A. H., Yates J., Sandhu M. S., Higgins J. P. T., The association between the peroxisome proliferator-activated receptor- 2 (PPARG2) Pro12Ala gene variant and type 2 diabetes mellitus: a HuGE review and meta-analysis American Journal of Epidemiology 2010 171 6 645 655
33. Andersen V., Christensen J., Ernst A., Polymorphisms in NF- B, PXR, LXR, PPAR and risk of inflammatory bowel disease World Journal of Gastroenterology 2011 17 2 197 206
34. Shrestha U. K., Karimi O., Crusius J. B., Zhou F., Wang Z., Chen Z., Van Bodegraven A. A., Xiao J., Morré S. A., Wang H., Li J., Xia B., Distribution of peroxisome proliferator-activated receptor-gamma polymorphisms in Chinese and Dutch patients with inflammatory bowel disease Inflammatory Bowel Diseases 2010 16 2 312 319
35. Aoyagi Y., Nagata S., Kudo T., Fujii T., Wada M., Chiba Y., Ohtsuka Y., Yamashiro Y., Shimizu T., Ohkusa T., Peroxisome proliferator-activated receptor 2 mutation may cause a subset of ulcerative colitis Pediatrics International 2010 52 5 729 734
36. Leung E., Hong J., Fraser A. G., Merriman T. R., Vishnu P., Krissansen G. W., Peroxisome proliferator-activated receptor- gene polymorphisms and Crohn's disease International Journal of Colorectal Disease 2007 22 4 453 454 (Pubitemid 46336252)
37. Wang F., Tahara T., Arisawa T., Sakata M., Takahama K., Watanabe M., Hirata I., Nakano H., Polymorphism of peroxisome proliferator-activated receptor gamma is not associated to Japanese ulcerative colitis Hepato-Gastroenterology 2008 55 81 73 75 (Pubitemid 351462166)